Skip to main
IVVD
IVVD logo

Invivyd Inc (IVVD) Stock Forecast & Price Target

Invivyd Inc (IVVD) Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 80%
Buy 20%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Invivyd Inc. is on a positive trajectory due to its innovative antibody-based solutions for infectious diseases, particularly its product PEMGARDA, which has shown stable neutralizing activity against dominant SARS-CoV-2 variants, thereby reinforcing its potential utility among high-risk populations. The company's commitment to addressing unmet needs, particularly for immunocompromised individuals, is underscored by the acceleration of development for VYD2311, which indicates a proactive approach in enhancing its product pipeline. Additionally, the anticipated market launch and intended focus on evolving viral strains present a robust opportunity for future revenue growth as healthcare providers gain further clarity on the efficacy and advantages of its therapeutic offerings.

Bears say

Invivyd Inc is experiencing significant regulatory challenges with its COVID-19 therapeutic candidates, particularly following the FDA's rejection of the expansion of PEMGARDA's Emergency Use Authorization (EUA), which directly impacts the company's market potential and immediate revenue forecasts. The decision emphasizes the difficulties in securing approvals for COVID-19 treatments, highlighting a critical need for the company to diversify its pipeline to sustain long-term growth prospects. Additionally, the current financial outlook is further complicated by the reliance on PEMGARDA's efficacy as a pre-exposure prophylactic for immunocompromised patients, leaving the company vulnerable in a competitive and rapidly evolving therapeutic landscape.

Invivyd Inc (IVVD) has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 80% of analysts recommend a Strong Buy, 20% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Invivyd Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Invivyd Inc (IVVD) Forecast

Analysts have given Invivyd Inc (IVVD) a Strong Buy based on their latest research and market trends.

According to 5 analysts, Invivyd Inc (IVVD) has a Strong Buy consensus rating as of Jul 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $7.11, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $7.11, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Invivyd Inc (IVVD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.